Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tsubota LaboratoryTSE:4890 60 EV-to-EBIT is -9.89 as of Aug. 30, 2026. GuruFocus rates TSE:4890 with a GF Score™ of 60/100 and a GF Value™ of 円95.67 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 477 Medical Devices & Instruments companies, Tsubota Laboratory ranks worse than 209643.4% on this metric.
The historical rank and industry rank for Tsubota Laboratory's EV-to-EBIT or its related term are showing as below:
TSE:4890'
s EV-to-EBIT Range Over the Past 10 Years
Min: -209.4 Med: -7.08 Max: 1542.95
Current: -9.89
During the past 7 years, the highest EV-to-EBIT of Tsubota Laboratory was 1542.95. The lowest was -209.40. And the median was -7.08.
TSE:4890's EV-to-EBIT is ranked worse than 100% of 477
companies
in the Medical Devices & Instruments industry
Industry Median: 18.99
vs TSE:4890: -9.89
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Tsubota Laboratory's Enterprise Value for the quarter that ended in Mar. 2026 was 円6,682.8 Mil.
Tsubota Laboratory's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-692.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsubota Laboratory EV-to-EBIT Related Terms
Tsubota Laboratory EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Tsubota Laboratory's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tsubota Laboratory's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tsubota Laboratory EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tsubota Laboratory's EV-to-EBIT falls into.
Tsubota Laboratory's current Enterprise Value is 円6,844.7 Mil.
Tsubota Laboratory's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-692.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tsubota Laboratory (TSE:4890) has a EV-to-EBIT of -9.89 as of Aug. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tsubota Laboratory and its competitors. According to the industry distribution chart, Tsubota Laboratory ranks #999999 out of 477 companies in the Medical Devices & Instruments industry.
Is Tsubota Laboratory's EV-to-EBIT too high?
Tsubota Laboratory's current EV-to-EBIT is -9.89. Based on the distribution chart, Tsubota Laboratory ranks #999999 out of 477 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tsubota Laboratory has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tsubota Laboratory's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Tsubota Laboratory ranks #999999 out of 477 companies for EV-to-EBIT. This places Tsubota Laboratory in the lower half of its industry. The industry median EV-to-EBIT is 18.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.99, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Tsubota Laboratory and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tsubota Laboratory's current EV-to-EBIT is -9.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tsubota Laboratory stock overvalued right now?
Based on GuruFocus' analysis, Tsubota Laboratory (TSE:4890) is currently considered Significantly Overvalued. The stock's GF Value™ is 円95.67, compared to a current price of 円290.00 — trading 203.1% above its estimated fair value. The current EV-to-EBIT is -9.89. Tsubota Laboratory's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Tsubota Laboratory (TSE:4890), the current EV-to-EBIT is -9.89 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tsubota Laboratory (TSE:4890) Overvalued in 2026?
Based on GuruFocus' analysis, Tsubota Laboratory stock appears to be overvalued.
The current stock price of 円290.00 is trading 203.1% above its estimated GF Value™ of 円95.67.
GuruFocus considers Tsubota Laboratory to be Significantly Overvalued.
Key valuation signals for TSE:4890:
EV-to-EBIT: -9.89
GF Value™: 円95.67 vs. price of 円290.00 (203.1% above fair value)
No single metric tells the full story. See the TSE:4890 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.
60GF Score
Get the complete analysis for TSE:4890
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4890 has been successfully added to your 
